How important is exact balance in treatment and control sample sizes to evaluations?

Journal of Substance Abuse Treatment

Volumn 33, Issue 1, 2007, Pages 107-110

  Elliott, Marc N ^a   McCaffrey, Daniel F ^a   Lockwood, J R ^a  

^a RAND CORPORATION   (United States)

Author keywords

Blocking; Confidentiality; Design; Evaluation; Power

Indexed keywords

ARTICLE; CONFIDENTIALITY; CONTROL GROUP; DRUG DEPENDENCE TREATMENT; EVALUATION; METHODOLOGY; PRIORITY JOURNAL; RANDOMIZATION; SAMPLE SIZE; STATISTICAL CONCEPTS; ADDICTION; HUMAN; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STATISTICS;

HUMANS; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SUBSTANCE-RELATED DISORDERS;

EID: 35248878209     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2006.12.007     Document Type: Article

References (8)

1. Berger V.W. Selection bias and covariate imbalances in randomized clinical trials (2005), John Wiley and Sons, Ltd, Chichester, West Sussex, England
2. Efron B. Forcing a sequential experiment to be balanced. Biometrika 58 (1971) 403-417
3. Hedden S.L., Woolson R.F., and Malcolm R.J. Randomization in substance abuse clinical trials. Substance Abuse Treatment, Prevention, and Policy 1 (2006) 6
4. In: Kadane J.B. (Ed). Bayesian methods and ethics in clinical trial design (1996), Wiley, New York
5. Matts J.P., and Lachin J.M. Properties of permuted-block randomization in clinical trials. Controlled Clinical Trials 9 (1988) 327-344
6. Palmer C.R., and Rosenberger W.F. Ethics and practice: Alternative designs for phase III randomized clinical trials. Controlled Clinical Trials 20 (1999) 172-186
7. Shadish W.R., Cook T.D., and Campbell D.T. Experimental and quasi-experimental designs for generalized causal inference (2002), Houghton Mifflin Company, Boston
8. Wei L.J., and Lachin J.M. Properties of the urn randomization in clinical trials. Controlled Clinical Trials 9 (1988) 365-374